Gary Goldenberg, Chief Medical Officer at Verrica Pharmaceuticals Inc. (VRCA), sold 36,928 shares at $7.06 ($261K) on 2024-07-22, disclosed to the SEC on 2024-07-23.
Open-market sale of $261k VRCA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.06 | 18,421 | $130K | 49.9% |
| 2 | $7.06 | 18,421 | $130K | 49.9% |
| 3 | $6.98 | 86 | $600 | 0.2% |
| Total | $7.06 avg | 36,928 | $261K | 100% |
| Filing → |
| VRCA | SELL | 2023-07-25 | $277K | — | Filing → |
| VRCA | BUY | 2022-07-05 | $50K | — | Filing → |